Sunlink Health Systems Inc (SSY) Return on Assets ROA from the third quarter of 2025 to third quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket
 


Sunlink Health Systems Inc   (NYSEAMER: SSY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Sunlink Health Systems Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sunlink Health Systems Inc 's ROA in the third quarter of 2025?
Sunlink Health Systems Inc achieved a return on average assets (ROA) of 9.13 % in its third quarter of 2025, this is above SSY's average return on assets of 0.33%.
Sunlink Health Systems Inc assets over the 12 months ending in its third quarter of 2025 are valued at $19 million

ROA has improved compared to 5.39% in the second quarter of 2025, due to net income growth.

However, within the Healthcare sector 95 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 680, from total ROA ranking in the second quarter of 2025 at 1316.

What is ROA?



Return On Assets (Mar 31 2025)
III. Quarter
(Dec 31 2024)
II. Quarter
(Sep 30 2024)
I. Quarter
(Jun 30 2024)
IV. Quarter
(Mar 31 2024)
III. Quarter
Y / Y Total Assets Change 8.88 % -4.87 % -9.64 % -37.17 % -34.31 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 2 1 -1 -2 -7
Return On Assets (TTM) 9.13 % 5.39 % -3.9 % -7.91 % -32.41 %
SSY's Total Ranking # 680 # 1316 # 3070 # 3308 # 4111
Total Assets (TTM) in million 17 18 20 21 16
Seq. Total Assets Change -2.23 % -8.95 % -4.77 % 28.43 % -14.57 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 96
Overall # 671

Return On Assets Statistics
High Average Low
53.26 %
0.33 %
-57.5 %
(Dec 31 2020)   (Jun 30 2016)





Financial Statements
Sunlink Health Systems Inc 's Assets $ 17 million SSY's Balance sheet
Sunlink Health Systems Inc 's Income $ -1 million Quarterly SSY's Income Statement
SSY's Income by Division See SSY's Income by Division



Annual Return On Assets (Jun 30 2024)
FY 2024
(Jun 30 2023)
FY 2023
(Jun 30 2022)
FY 2022
(Jun 30 2021)
FY 2021
(Jun 30 2020)
FY 2020
Y / Y Total Assets Change -11.42 % -38 % 43.38 % -44.85 % -20.57 %
Total Assets in million 21 23 38 26 47
Y / Y Net Income Change - - - - -
Net Income in million -2 -2 -2 7 -1
Annual Return On Assets -7.41 % -7.71 % -5.35 % 26.32 % -2.4 %




More Return On Assets Ratios
SSY's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SSY's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SSY's Competitors
Subscribers only: Roa for Sunlink Health Systems Inc 's Suppliers
Subscribers only: Return On Assets for SSY's Customers

You may also want to know
SSY's Roi SSY's Inventory Turnover Ratio SSY's Growth Rates SSY's Dividend Comparisons
SSY's Profitability Ratios SSY's Asset Turnover Ratio SSY's Dividend Growth
SSY's Roe SSY's Valuation Ratios SSY's Financial Strength Ratios SSY's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA
Hims and Hers Health Inc   24.52 %
Rigel Pharmaceuticals Inc  24.47 %
Catalyst Pharmaceuticals Inc   24.37 %
Halozyme Therapeutics Inc   23.26 %
Whitehawk Therapeutics Inc   22.47 %
Siga Technologies Inc  22.07 %
Acadia Pharmaceuticals Inc   21.74 %
Medpace Holdings Inc   20.81 %
Carlisle Companies Incorporated  20.64 %
Iradimed Corporation  20.60 %
Third Harmonic Bio Inc   18.67 %
Nrc Health  18.67 %
Resmed Inc   18.41 %
Puma Biotechnology Inc   18.23 %
Chemed Corporation  17.90 %
Zoetis Inc   17.58 %
Abbott Laboratories  17.41 %
Champions Oncology Inc   17.31 %
Pro dex Inc   16.76 %
United Therapeutics Corporation  16.73 %
Corcept Therapeutics Inc  16.64 %
Alkermes Plc   16.60 %
Mimedx Group Inc   15.94 %
Harmony Biosciences Holdings inc   15.90 %
Minerva Neurosciences Inc   15.73 %
Stoke Therapeutics Inc   15.72 %
Merck and Co Inc   15.10 %
Prestige Consumer Healthcare Inc   14.95 %
Biomx Inc  14.82 %
Waters Corporation  14.47 %


Date modified: 2026-09-08T15:11:30+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.